comparemela.com

Latest Breaking News On - Gastrointestinal health - Page 21 : comparemela.com

Elizabeth Cherry, PharmD, MMHC, CSP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Importance of Patient Navigation in Specialty Pharmacy

Many patients face significant challenges in accessing their specialty medications, which highlights the importance of pharmacy-deployed patient navigation programs designed to help resolve nonclinical, system-related barriers to care.

Justin Lindhorst, MBA

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Roche s Multi-Billion Dollar Move: Acquisition of Bowel-Disease Drug Developer from Roivant Sciences and Pfizer

Swiss pharmaceutical giant Roche has announced its intention to acquire the developer of a promising bowel-disease treatment.

CDC Issues Alert to Address Shortage of RSV Treatment Nirsevimab

Nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) is a monoclonal antibody approved to prevent against respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants under 8 months of age born during or entering their first RSV season.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.